上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1286Please respect copyright.PENANApPCDBtmzQu
1286Please respect copyright.PENANAqypi5RwgR4
上集:https://www.penana.com/article/4711251286Please respect copyright.PENANAPAK8r0gv9M
1286Please respect copyright.PENANACEyjJzlUjN1286Please respect copyright.PENANA1CV2phnPWQ
1286Please respect copyright.PENANA3ighOGXzQD
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1286Please respect copyright.PENANA2iy02nrPsA
1286Please respect copyright.PENANAGZmDioGiyO
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1286Please respect copyright.PENANACrdzjUWiUX
1286Please respect copyright.PENANAo7Orr2SOjG
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1286Please respect copyright.PENANADSwLKuljCc
1286Please respect copyright.PENANAUgJiMnYhE21286Please respect copyright.PENANA03eZqS63yP
1286Please respect copyright.PENANAWnYLDbJWET
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1286Please respect copyright.PENANAm3TRI341OA
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1286Please respect copyright.PENANAefXK2EBsK7
1286Please respect copyright.PENANAYNPrEb1JIi
忘記甚麼是Neoantigen的話,可重溫上一集。1286Please respect copyright.PENANAXRqiXNpX4p
1286Please respect copyright.PENANA2uVlNhn18A
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1286Please respect copyright.PENANA86uwnz2aDv
1286Please respect copyright.PENANAmgMcLrLM19
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1286Please respect copyright.PENANApjDLwGUVEz
1286Please respect copyright.PENANA7DDF320hc31286Please respect copyright.PENANAbY8x5G4iro
1286Please respect copyright.PENANAraDKTpiLgV
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1286Please respect copyright.PENANAqDiHt1z7le
1286Please respect copyright.PENANAuud92A7pkB
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1286Please respect copyright.PENANAHlhrjKeQdq
1286Please respect copyright.PENANAUsh4gU1D6P
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1286Please respect copyright.PENANAE4i11xIzVV1286Please respect copyright.PENANANU85xJ62FR
1286Please respect copyright.PENANA5ZLmt7wSO9
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1286Please respect copyright.PENANAxx7Eq213Tj
1286Please respect copyright.PENANANRVcTxtBoV
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1286Please respect copyright.PENANAz37AoWt6nm1286Please respect copyright.PENANAKaPMiojbHb
1286Please respect copyright.PENANAQe61hg37QZ
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1286Please respect copyright.PENANAlKaPsRKBdo
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1286Please respect copyright.PENANADruMA3JBWO
1286Please respect copyright.PENANAKfXbh7mIFa
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1286Please respect copyright.PENANA9I93Q99h1q
1286Please respect copyright.PENANAz62SticUvF
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1286Please respect copyright.PENANAcmEuhsMstx
1286Please respect copyright.PENANAL2FKUyVlAv
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1286Please respect copyright.PENANAiuSyv38OgG
1286Please respect copyright.PENANA1b3rFgvahu
1286Please respect copyright.PENANAwyMPMhuggk
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1286Please respect copyright.PENANAyym10aDilO
1286Please respect copyright.PENANA1fnNtKnNOW
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1286Please respect copyright.PENANAItRmNmtor4
1286Please respect copyright.PENANA1bDvOSD30p
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1286Please respect copyright.PENANAERxTyHVhPo
1286Please respect copyright.PENANA526lHUXJQH
Link:1286Please respect copyright.PENANAlFp447KhWh
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1286Please respect copyright.PENANAVJ5DgR5fdk
1286Please respect copyright.PENANAnJtqSFVTIJ
1286Please respect copyright.PENANAaYVXuuUqU4
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1286Please respect copyright.PENANAtqPRD2AgGm